Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710172 · ClinicalTrials.gov registry record · NA
Evaluation of Auditory Mirror-therapy for Tinnitus
A NA study of Tinnitus, sponsored by Spaulding Rehabilitation Hospital.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05710172: Active NA study of Tinnitus, sponsored by Spaulding Rehabilitation Hospital.
NCT05710172 is a NA study of Tinnitus that is active but no longer recruiting, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 50 participants, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05710172, a NA study of Tinnitus, is active but no longer recruiting, sponsored by Spaulding Rehabilitation Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will evaluate the effects of wearing auditory mirror earmuffs on tinnitus and on audiometry.The auditory mirror earmuffs is a device that re-routes auditory input from the left side of the head to the right ear, and vice verse, thereby flipping the auditory input. This procedure is called Auditory Mirror Therapy (AMT).
Primary Outcome
The Tinnitus Functional Index (TFI) is a 25-item questionnaire measuring tinnitus severity on a 0-100 scale. Scores are calculated by averaging item responses and scaling to 0-100, where higher scores signify greater distress. The change in TFI score between baseline and follow up is reported, with negative numbers indicating a decrease in tinnitus severity.
Conditions Studied
Interventions
- DEVICE Auditory Mirror Therapy
Study Locations (1)
Massachusetts
- Spaulding Rehabilitation Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-10-04 |
| Est. Completion | 2025-11-30 |
| Phase | NA |
What the registry record for NCT05710172 still lists
NCT05710172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 1 intervention - of which Auditory Mirror Therapy is the first listed.
NCT05710172 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05710172 about?
NCT05710172 is a clinical study titled "Evaluation of Auditory Mirror-therapy for Tinnitus". The investigators will evaluate the effects of wearing auditory mirror earmuffs on tinnitus and on audiometry.The auditory mirror earmuffs is a device that re-routes auditory input from the left side of the head to the right ear, and vice verse, thereby flipping the auditory input. This procedure is...
What is the current status of trial NCT05710172?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-10-04. Estimated completion is 2025-11-30.
What conditions does trial NCT05710172 study?
This clinical trial studies the following conditions: Tinnitus.
What interventions are being tested in trial NCT05710172?
The interventions under investigation include: Auditory Mirror Therapy (DEVICE).
Who is sponsoring clinical trial NCT05710172?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05710172 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05710172's enrollment target sits among peer trials
50 17th of 24 higher than 8 of 24 other Tinnitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tinnitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
RECRUITING · NA
-
Somatosensory Tinnitus RCT
RECRUITING · NA
-
Noninvasive Therapy for Tinnitus
RECRUITING · NA
-
External Therapy for Tinnitus Management
RECRUITING · NA
-
Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI